Notebook

Rita Colwell GOOD-BYE ... ALMOST On July 10, University of Maryland bid a bittersweet "almost farewell" to Rita Colwell, who left the position of president of the university's Biotechnology Institute (UMBI) to become director of the National Science Foundation (NSF). Colwell's farewell to UMBI is only partial--she has committed herself to one day of research per week in her laboratory, where she studies, particularly, the bacteria that cause cholera. On hand July 10 to congratulate her and wi

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Rita Colwell GOOD-BYE ... ALMOST On July 10, University of Maryland bid a bittersweet "almost farewell" to Rita Colwell, who left the position of president of the university's Biotechnology Institute (UMBI) to become director of the National Science Foundation (NSF). Colwell's farewell to UMBI is only partial--she has committed herself to one day of research per week in her laboratory, where she studies, particularly, the bacteria that cause cholera. On hand July 10 to congratulate her and wish her well were friends and colleagues from the university, the biotechnology industry, government, and politics. Maryland Lt. Gov. Kathleen Kennedy Townsend and others lauded Colwell for her vision in the early 1980s that led to the establishment of Maryland as a world-class center for biotechnology. Colwell accomplished this feat by adding a total of six research centers to UMBI and by encouraging the growth of Maryland's biotech industry. Townsend declared that in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies